Visa Agrees to Acquire Majority Interest in Payments Processor Prosa

[ad_1] Visa entered into an agreement to acquire a majority interest in Prosa, a payments processor in Mexico. The payments-networks company said Prosa will operate as an independent company with…

Merck MS Drug Fails to Meet Target of Late-Stage Trials

[ad_1] Merck’s multiple sclerosis drug evobrutinib didn’t meet a key goal in late-stage trials. The German pharmaceutical company’s phase 3 clinical trials for the drug did not achieve their primary…

Bayer Shares Tumble After Clinical Trial Failure, Loss in Roundup Case

[ad_1] Updated Nov. 20, 2023 3:16 pm ET Bayer shares fell sharply after the company stopped a late-stage study for a blood-thinning drug early because of lack of efficacy and…

OpenAI Glitch Shows Weaknesses in Microsoft’s AI Armor

[ad_1] Microsoft may have put out a five-alarm fire around its most important technology move in years. But fires leave scorch marks—and sometimes flare up again.  A leadership crisis at…

WSJ News Exclusive | The Next Hot Obesity Drug Won’t Be Approved for Years. Online Sellers Hawk It Anyway.

[ad_1] Eli Lilly’s retatrutide will be in clinical trials for the next three years, but knockoff versions already abound. [ad_2] Source link

Please Support This Ice Maker: Big Manufacturers Try Crowdfunding to Market-Test Products

[ad_1] GE Appliances and others seek customer feedback and payment in advance to help validate a concept. [ad_2] Source link

Opinion | Proper Nutrition Can Prevent Postpartum Depression

[ad_1] The new drug is a breakthrough, but taking calcium during pregnancy may minimize the need for it. [ad_2] Source link

WSJ News Exclusive | Sweetgreen Hires Former Chipotle Executives, Readies Mid-America Push

[ad_1] Sweetgreen hired two former Chipotle Mexican Grill executives to lead its marketing and culinary development, part of the salad chain’s strategy to expand beyond large metropolitan areas on the…

The AI Trade Faces Its First Major Test With Nvidia Earnings

[ad_1] The chip maker’s rosy forecast lifted markets in a turbulent time—but the bar to dazzle investors is higher now. [ad_2] Source link

Doctors Transplanted a Pig Kidney Into a Person a Month Ago. It’s Still Working.

[ad_1] A genetically modified pig kidney transplanted into a brain-dead person has worked for 32 days and counting, advancing efforts to use animals to ease perennial shortages for humans. [ad_2]…